VASCEPA
Identification of Vascepa
| No description |
Google image searchProduct monograph
Active ingredient
icosapent ethyl, 1 G
DIN: 02495244
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: HLS THERAPEUTICS INC
Date: 07-FEB-2020
ATC:
- C10 — LIPID MODIFYING AGENTS (ATC, ATC/DDD, )
- C10A — LIPID MODIFYING AGENTS, PLAIN (ATC, ATC/DDD)
- C10AX — Other lipid modifying agents (ATC, ATC/DDD)
